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Cofactors Are Essential for Stem Cell Factor-Dependent Growth and Maturation of Mast Cell Progenitors: Comparative Effects of Interleukin-3 (IL-3), IL-4, IL-10, and Fibroblasts
By Donna Rennick, Brisdell Hunte, Gina Holland, and LuAnn Thompson-Snipes Stem cell factor (SCF) possesses many mast cell-stimulating activities, including the ability to support the growth of mucosal-like mast cells (MMCs) and connective tissue mast cells (CTMCs) . However, this study shows that, in the absence of accessory cells, SCF does not stimulate the clonal growth of primitive mast cell progenitors. Nevertheless, SCF exhibited potent growth-promoting effects when combined with the cytokines interleukin-3 (IL-3). interleukin-4 (IL-4). and interleukin-l0 (IL-10). Our comparative studies have shown that optimal mast cell colony formation occurs when both IL-4 and IL-10 are combined with SCF. However, in the presence of SCF, these two cofactors appear to mediate different effects. IL-4 was more efficient than L 1 0 in costimulating the initiation of SCF-dependent colony formation by mast cell progenitors and in sustaining the proliferation of newly generated progeny. On the other hand, IL-4 was less efficient than IL-10 in supporting mast cell differentiation, as evidenced by morphology, cell enlargement, and REVIOUS STUDIES have shown that stem cell factor (SCF) is produced by fibroblasts and that its interaction with its receptor c-kit is critical for the development of melanocytes, germ cells, and hematopoietic cells, including mast cells.',' SCF, produced in either membrane-bound or soluble appears to influence many aspects of mast cell development. Membrane-bound SCF mediates the attachment of mast cells to fibroblasts, presumably by serving as an adhesion m01ecule.~ Additionally, SCF can enhance the adherence of mast cells to fibronectin, which is a component of connective tissue m a t r i~.~ SCF also acts as a potent mast cell chemoattractant6 and promotes the survival' and proliferation of immature, morphologically identifiable mast cell^^^^ as well as mature connective tissue mast cells (CTMCS).~-'~ Other studies indicate that SCF has a spectrum of activities affecting mast cell and mediator re1ea~e.I~"~ Nevertheless, it appears that factors in addition to SCF are required for full maturation of CTMCs leading to characteristic ultrastructural change^,'^ expression of high affinity receptor for IgE,Ix heparin proteoglycan s y n t h e s i~,~-'~.~~ and high levels of histamine prod~ction.'.'~ The results of these in vitro studies have begun to define the specific mast cell-stimulating activities of SCF, the lack of which may account for the absence of mast cells in the mucosal and connective tissues of W W and SVSld m i~e . '~.~' These mice have mutations in the S1 locus encoding SCF (c-kit ligand)*"*' or in the W locus encoding the receptor for SCF kit).*^ Although the tissues of W W and SVSld mice are virtually devoid of mast cells, the bone marrow of these animals contains normal numbers of mast cell progenitor^.'^ Therefore, the importance of SCF in regulating very early stages of mast cell development is questionable. Recently, SCF has been shown to support the outgrowth of mast cells in human and murine progenitor cell ~u l t u r e s . '~~~~-~~ Although these studies clearly indicate that SCF has potent stimulatory effects on early precursors, it remains unclear whether SCF alone is sufficient to support their growth, because accessory cells were present in the starting populations or were gener-P Blood, Vol 85, No 1 (January l), 1995: pp 57-65 granule production. Although the actions of IL-4 and IL-10 were not equivalent, additional experiments indicated that their ability to serve as early-and late-acting factors, respectively, were complimentary. We have also found that the mast cells generated in colonies stimulated by IL-4, IL-IO, and SCF produced high levels of histamine (6-8 pg per cell). None of the mast cells generated in our cultures synthesized heparin. A phenotypic change from safranin-negative to safranin-positive cells associated with heparin-producing CTMCs was accomplished after coculture of the mast cells with fibroblast cell lines derived from normal mice or from SI/Sld mice plus soluble factors. Collectively, our observations demonstrate that SCF acts as a competence factor for mast cell progenitor growth. In addition, the ability of SCF to support certain stages of mast cell differentiation is profoundly influenced by interactions with specific cofactors. 0 1995 by The American Society of Hematology.
ated after initiation of high density cell cultures. Therefore, we have assessed the direct stimulatory effects of SCF on committed mast cell progenitors. We have also used SCF in combination with various cytokines and fibroblast cell lines to identify interactions that may provide optimal expansion and differentiation of primitive mast cell progenitors.
MATERIALS AND METHODS
Animals. C57B116 mice were purchased from Simonsen Laboratory (Gilroy, CA). WCB6F,-SVSld mice were provided by S. Galli (Harvard Medical School, Boston, MA).
Cytokines and antibodies. Purified recombinant murine interleukin-4 (IL-4; specific activity, 6 X IO7 U1mg) was provided by Schering-Plough Research (Bloomfield, NJ). Purified recombinant murine interleukin-3 (IL-3; specific activity, 1.5 X IO8 Ulmg) and interleukin-l0 (IL-IO; specific activity, 2 X lo7 U h g ) were gifts of A. Miyajima and W. Dang, respectively (DNAX, Palo Alto, CA). Purified recombinant murine SCF was provided by C. Hannum (DNAX). One standard unit of SCF is defined as the amount of factor necessary to stimulate a half-maximal proliferative response by the NFS-60 myeloid cell line (specific activity, 5 X 10' U1mg). Anti-IL-4 (11B11). anti-IL-3 (19B3.11), anti-IL-l0 (JES5-2A5), and antiEscherichia coli beta-galactosidase (GL113) monoclonal antibodies were supplied by J. Abrams (DNAX). Cell lines secreting anti-CD4 (GK1.5). anti-CD8 (53.6.72). anti-CD3 (KT3-l.l), and anti-Mac 1 (M1170.15.11 S ) monoclonal antibodies were obtained from the 58 RENNICK ET AL American Type Culture Collection (Rockville, MD). Anti-B220 (RA3-6B2) and anti-Gr-l (RB6-8C5) monoclonal antibodies were provided by R. Coffman (DNAX).
Infection with Nippostrongylus brasiliensis (Nb). Nb larvae were maintained by passage through rats as described." C57BY6 mice were injected subcutaneously with 1,000 stage 3 larvae and were killed 14 days later. Clonal mast cell assay. Mesenteric lymph nodes were removed from Nb-infected mice 14 days after infection and were disaggregated to produce single cell suspensions. The cells (5 X lo7 c/mL) were incubated with fluorescein isothiocyanate (FITC)-conjugated anti-CD3, anti-CD4, anti-CDS, anti-B220, anti-Mac 1, and anti-Gr-I at 4°C for 30 minutes. The cells were washed, pelleted, and incubated with goat-antirat IgG-coated and sheep anti-FITC IgG-coated magnetic beads (Advanced Magnetics Inc, Cambridge, MA) on a rotating platform for 30 minutes at 4°C. Antibody-coated cells were removed by a Bio-Mag magnet (Advanced Magnetics Inc). The remaining cells were subjected to a second treatment with magnetic beads and magnetic separation. The population recovered after two rounds of depletion typically represented 5% to 6% of mesenteric lymph node cells (MLNCs) and contained less than 2% lineage marker-positive cells by FACS analysis. Unseparated and depleted MLNCs were cultured at several concentrations in modified Iscove's medium (GIBCO, Grand Island, NY), 10% fetal calf serum (FCS), 0.8% (wthol) methylcellulose, 50 pmol/L 2-mercaptoethanol (2-ME), and saturating concentrations of various growth factors. Each of these cultures was fed weekly with the same growth factors used to initiate the cultures unless otherwise specified. Anti-IL-3, anti-IL-4, and anti-IL-IO monoclonal neutralizing antibodies were used in some experiments and were added once either at the initiation of culture or 5 days later as specified. Each antibody was used at 10 pg/mL to neutralize a minimum of 200 U/mL of specific cytokine as shown by titration experiments using factor-dependent cell lines. None of these antibodies had any effect on the SCF-dependent growth of NFS-60 cells. An equivalent amount of anti-beta-galactosidase antibody was used as an isotype control. The size and number of colonies were scored after 7, 14, and 21 days of culture.
Coculture of mast cells withjibroblasts. Mast cell colonies were harvested from 3-week-old methylcellulose cultures and washed two times with Hanks' balanced salt solution, and 1 X IO" cells from each type of culture were transferred into 24-well tissue culture plates (Coming, New York, NY) containing cytokines (specified in Results). Equal numbers of cells were also transferred into 24-well tissue culture plates containing a monolayer of the fibroblast cell line, 30R," derived in our laboratory from bone marrow of CBNJ mice. Similar cultures were established using a monolayer of the fibroblast cell line ST5 derived in our laboratory from bone marrow of WCB6F,-SUSld mice. Some of the cultures were fed weekly with growth media supplemented with cytokines. Cells were recovered for analysis after 3 weeks of coculture.
Staining of cultured cells. Mast cells recovered from methylcellulose cultures and from fibroblast cocultures were transferred onto glass slides and stained with 1% toluidine blue (pH 1.0; Sigma, St.
Louis, MO) or with Wright-Giemsa (Sigma) for morphologic analysis, To identify mucosal and connective tissue mast cells, additional slides were fixed in Carnoy's fixative and stained with berberine sulfate (Sigma)" and alcian blue followed by safranin (Rowley Biochemical Institute, Rowley, MA).'* CTMCs from the peritonea of normal mice were used as positive controls for heparin staining. The specificity of the heparin staining with berberine sulfate was tested using heparinase (Seikagaku Corp, Tokyo, Japan) and chondroitinase ABC (Seikagaku) according to published methods."
Hisfamine analysis. Histamine content was determined using a competition radioimmunoassay kit as specified by the manufacturer (Amac Inc, Westbrook, ME). A minimum of 1 X IO" mast cells from 3-week-old cultures was used for each assay sample.
RESULTS
S W does not stimulate the clonal growth of mast cell precursors in accessory cell-depleted cultures. The ability of SCF to support the growth of mast cell progenitors was evaluated in colony forming assays using MLNCs isolated from Nb-infected mice. Unseparated MLNCs were cultured at three concentrations ( 2 X 105/mL, 4 X 105/mL, and 6 X 105/mL) in methylcellulose supplemented with varying amounts of SCF. These preliminary experiments showed that maximal colony formation required 10' U/mL of SCF, which is equivalent to 200 ng/mL (data not shown). However, the results of these preliminary experiments and those in Fig 1 show that the numbers of colonies observed were not directly proportional to the numbers of cells plated. The disproportionately greater numbers of colonies detected at the higher cell concentrations suggested that the growth of mast cell progenitors was not dependent entirely on SCF and may have involved contributions from accessory cells. This possibility was supported by two observations. First, SCF-stimulated colony formation was completely abolished when MLNC cultures contained a mixture of neutralizing monoclonal antibodies specific for IL-3, 1L-4, and IL-l0 (Fig 1) .
Second, SCF did not support colony formation by MLNCs depleted of cells bearing lineage markers of T cells, B cells, macrophages, and other myeloid cells (Lin-MLNCs) (Fig 2). T cells are an excellent source of IL-3, IL-4, and IL-
whereas B cells and macrophages produce IL-10.75~'h To insure that Lin-MLNCs still contained substantial numbers of progenitor cells, cultures supplemented with IL-3 or with IL-3 + IL-4 + IL-10 were established as positive controls. In contrast with SCF, these factors supported mast cell colony formation by Lin-MLNCs, and the numbers of colonies generated increased in direct proportion to the numbers of cells plated, reflecting their absolute dependence on exogenous factors (Fig 2) .
Effects of dgfferent cofactors on SCF-induced mast cell progenitor growrh. The fact that a mixture of neutralizing antibodies specific for IL-3, IL-4, and IL-10 had blocked SCF-stimulated growth of unseparated MLNCs suggested that one or more of these cytokines was required for progenitor cell growth in response to SCF. Accordingly, LinMLNCs ( 2 x 105/mL) were cultured in methylcellulose containing various combinations of SCF, IL-3, IL-4, and IL-10. The combination of SCF and IL-3 stimulated more mast cell colonies than did IL-3 alone (Fig 3) . This result was not unexpected because SCF and IL-3 interact synergistically in stimulating the generation of mast cells as well as other hematopoietic lineages from primitive murine bone marrow ~e l l s .~' .~~ It was also found that IL-4 and IL-10 could serve as cofactors for SCF-induced growth. By comparison, the combination of IL-4 and SCF consistently stimulated more as well as larger colonies than did either IL-l0 + SCF or In a previous study, it was shown that while either IL-4 or IL-10 could interact synergistically with L -3 to stimulate the clonal growth of mast cell progenitors, the simultaneous IL-3 + SCF. presence of IL-4 and L-10 resulted in an even greater enhancement of IL-3-dependent growth with respect to colony numbers and size.39 In the present study, the combined effects of L-4, L-10, and SCF did not lead to greater colony numbers than did L -4 + SCF (Fig 3) . However, the combination of IL-4 + IL-10 + SCF appeared to increase the number of cells per colony (Table 1) .
Morphologic analysis of mast cell colonies. After 2 weeks of incubation, colonies stimulated with the factor combinations shown in Fig 3 were inspected by phase-contrast microscopy, and differences in colony morphology were observed. For example, colonies supported by IL-4 + SCF were large with diffuse borders and contained uniformly small cells (Fig 4A) . When cytospun cells from these colonies were stained with Wright-Giemsa, they were found to consist entirely of mast cells, which exhibited a modest amount of basophilic cytoplasm and low numbers of granules ( Fig 4C) .
In contrast, colonies grown in IL-10 + SCF were smaller, with well-defined borders, and contained large cells ( Fig   4B) . Histologic examination of individual colonies showed pure mast cell populations displaying ample neutrophilic cytoplasm as well as numerous granules (Fig 4D) . IL-3 + SCF induced the formation of a small number of myeloid colonies (approximately three per culture) in addition to pure mast cell colonies.
Delayed addition experiments.
Delayed addition experiments were performed to test the possibility that IL-4 and IL-l0 mediate complimentary but distinct activities in the presence of SCF (Table 1) . When IL-4 was added 5 days after cultures were initiated with IL-l0 + SCF (group 4), both the number and size of colonies were reduced relative to those generated in cultures stimulated simultaneously with all three factors (group 1; P < .Ol) or with IL-4 + SCF (group 2; P < .OS). However, the number of cells per colony remained significantly higher than that obtained with IL-10 + SCF (group 3; P < .01). These results showed that IL-4 is required early to optimize both the number of progenitor cells initiating clonal growth and the expansion of their immediate descendants. In contrast, the delayed addition of IL-10 to cultures containing IL-4 and SCF (group S ) did not lead to significantly lower colony numbers. Interestingly, adding IL-l0 on day S still resulted in enhanced numbers of cells per colony (P < .01) similar to those observed when IL-10 was present from day 0 (group 1). Furthermore, the delayed addition of IL-10 permitted the development of cells with increased cell volume and granule content, indicating that IL-l0 can act later than IL-4 without diminution of its effects.
To determine whether continued stimulation by IL-4 was necessary for optimal IL-10 function, anti-IL-4 antibody and IL-10 were added simultaneously to cultures initiated 5 days before with IL-4 + SCF (group 6). This treatment resulted in a substantial reduction in the number of cells per colony (compare group 6 with groups 1 and 5; P < .01); however, it did not depress the late-acting effects of IL-10 on cell differentiation as determined by cell volume and granularity. These results show that even though IL-4 and IL-10 can act in sequence, their concerted actions are required to maximize SCF-dependent expansion of mast cells derived from progenitor cells.
We also found that colony formation initiated by IL-4 + IL-l0 + SCF was abolished if anti-IL-4 and anti-IL-l0 antibodies were added on day 5 (Table 1, group 8). Apparently, SCF is unable to support the continued proliferation of the earliest progeny derived from mast cell progenitors in the absence of other cofactors.
Histochemical analysis of mast cell colonies. Mast cells recovered from 3-week-old colonies were analyzed for their staining characteristics and histamine content ( Table 2 ). All cells showed metachromatic granules when stained with toluidine blue, which is consistent with their morphologic identification as mast cells. The alcian blue-safranin reaction was used to identify mast cells displaying a mucosal-like (alcian+/safranin-) or connective tissue-like (alcian+"l safranin+) phenotype. While cells from all groups stained with alcian blue, none reacted with safranin ( Table 2) . Safranin-staining has been correlated with heparin synthesis by CTMCs. The absence of heparin synthesis was confirmed by the absence of reactivity with the fluorescent dye, berberine sulfate (Table 2 ). Based on these criteria, it was concluded that cultured cells from all groups closely resembled mucosal mast cells.
Relatively low levels of histamine were detected in all mast cell populations with one exception (Table 2) * These numbers are different from those generated by SCF plus one other factor and from IL-3 + IL-4 + IL-10 at P < .01 by Student's t-test.
of these mast cells were also shown to contain heparin based on their heparinase-sensitive reaction with berberine sulfate. However, the precise quantification of berberine sulfate-reactive mast cells present in these cultures was impossible due to the highly autofluorescent nature of our cultured stromal cell line. Therefore, the phenotypic change in mast cells cultured on stromal cell lines has been analyzed by reactivity with safranin.
Cocultures were performed with and without cytokine supplementation. Although cultures treated with cytokines appeared to support a larger number of the transplanted mast cells (approximately fourfold), they did not support an appreciably greater proportion of cells reactive with safranin (Table 3). Further, there was no discernible difference among the mast cell populations with respect to their alcian blue/ safranin staining pattern under the influence of the 30R stromal monolayer with and without factors. Consistently, 50% or more of the cells stained only with alcian blue. This outcome did not change with time, as similar staining patterns were observed for all groups after an additional 3 weeks of coculture (data not shown).
Mast cells from the same primary methylcellulose cultures listed in Table 3 were also transferred into cultures supplemented with cytokines in the absence of stromal cells. Each group received the same cytokines used for their derivation. None of the mast cells reacted with berberine sulfate or safranin after 6 weeks of incubation in the presence of factor combinations that included SCF (data not shown). Their staining solely with alcian blue reflected the retention of a mucosal-like mast cell phenotype.
The finding that conversion from safranin-negative to safranin-positive cells could be accomplished on stromal cells from normal mice did not exclude a role for membranebound SCF in this maturation process. Therefore, mast cells were also cocultured with a monolayer of ST5 fibroblasts derived from the bone marrow of SVSld mice. These mice have been shown to be genetically defective in their ability to produce membrane-bound SCF. ' We found that all mast use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From cells died rapidly after transfer onto ST5 cells (Table 3) . However, when such cocultures were also supplemented with exogenous factors to support cell viability, substantial numbers of safranin-positive mast cells were recovered after 3 weeks.
DISCUSSION
In this study, the stimulatory effects of SCF on mast cell progenitors were evaluated. For this purpose, cells isolated from the mesenteric lymph nodes of parasitized mice were used because they contain significant numbers of committed mast cell progenitors4' and, unlike bone marrow, are almost devoid of myeloid progenitor^.^^.^' We have found that SCF is sufficient to stimulate mast cell colony formation by unseparated but not by accessory cell-depleted MLNCs (LinMLNCs). Further studies with Lin-MLNCs showed that the SCF-dependent growth of progenitor cells requires signaling by additional factors. This requirement can be met by IL-3, IL-4, or IL-10. The finding that SCF-dependent mast cell progenitor growth requires cofactors is consistent with other studies showing that the ability of SCF to induce the growth of multipotential, granulocyte, or erythroid progenitors also requires c~s t i m u l a n t s .~'~~~~'~ Although IL-3, IL-4, or IL-10 was able to costimulate SCF-dependent mast cell progenitor growth, our studies have focused primarily on the interactions between IL-4, IL-10, and SCF. In contrast with IL-3, these factors alone can not support progenitor growth. In the presence of SCF, IL-4 was superior to IL-10 in recruiting progenitor cells to initiate clonal growth and in supporting the continuous proliferation of daughter cells. Thus, IL-4 + SCF always stimulated more colonies and more mast cells per colony than did IL-10 + SCF. However, IL-4 appeared to be a relatively weak signal for mast cell differentiation as compared with IL-10. Thus, the mast cells recovered from colonies stimulated by IL-4 + SCF were always less mature in their appearance than those recovered from the small, less numerous colonies stimulated by IL-10 + SCF. We also found that the addition of IL-10 to cultures containing IL-4 and SCF did not lead to an additive effect with respect to the total number of colonies generated. Apparently, the low number of progenitor cells capable of responding to IL-10 + SCF represents a subset of those responsive to IL-4 + SCF. Therefore, it was not surprising that the delayed addition of IL-10 to cultures containing IL-4 + SCF did not diminish the total number of mast cell colonies formed. The fact that the delayed addition of IL-l0 still lead to a substantial increase in the number of cells per colony and in the appearance of large, well-granulated mast cells indicated that IL-l0 can function as a lateacting proliferation and maturation factor for progeny newly generated by IL-4 + SCF.
The finding that mast cells derived directly from progenitor cells stimulated with IL-4 and SCF exhibited mostly basophilic cytoplasm and few granules was somewhat surprising. One interpretation of this result is that neither IL-4 nor SCF have a strong inductive effect on the de novo synthesis of granules. Evidence that SCF may not play a critical role in granule synthesis has come from in vivo studies with W W mice. Mast cells with normal morphology including granule formation developed in the skin of these mice at sites of chronic dermatitis4* or after infusion with IL-3."' These in vivo studies do not exclude the possibility that SCF can help promote granule development. However, under the conditions of our in vitro assays, only IL-3 and IL-10 have been associated with significant granule production. We have also evaluated the effects of SCF and various cofactors on histamine production. Several investigators have found that mast cells generated in cytokine-stimulated bone marrow cultures produce more histamine after exposure to SCF.9,'2 While the level of histamine induced by SCF was found to be low (approximately 2 pg per cell) as compared with that exhibited by freshly isolated CTMCs (greater than 20 pg per cell), it was higher than that expected for mucosal mast cells (less than 1 pg per cell). In general, our results agree with these findings. Our data also show that the combination of IL-4 + IL-l0 + SCF results in 6 to 8 pg of histamine per cell, which is the highest value reported for cultured cells. This amount of histamine production required the concerted actions of these particular factors and could not be accomplished with other combinations (ie, IL-4 + SCF, IL-10 + SCF, or IL-3 + IL-4 + IL-10). Although SCF can influence histamine synthesis, this process is apparently regulated by multiple factors. Cytokines in addition to those identified herein may be involved in generating even higher levels of histamine normally found in freshly isolated CTMCs.
A role for SCF in the induction of heparin synthesis by maturing CTMCs was first inferred by the absence of this cell type in the tissues of W W and Sl/Sld m i~e . '~~~" This idea was further supported by the observation that immature mast cells synthesized heparin after coculture with fibrouse only. isolated from mouse peritoneum.'^'" In other studies, the target populations were either or human'* bone marrow progenitor cells. Although SCF was shown to support the development of heparin-positive cells, they were a minor population compared with the number of heparinnegative mast cells derived in these cultures.?'.'' Furthermore, even when bone marrow was first depleted of accessory cells, adherent "stromal populations"*' and macrophages** were generated. The fact that low numbers of heparin-positive cells were stimulated by SCF in conjunction with adherent-cell populations has raised questions about the role of this factor in de novo heparin synthesis by maturing mast cells. We have addressed these questions by using lineage-depleted MLNCs, which contain very few myeloid progenit~rs,'"~' and semisolid cultures, which diminish cellular interactions. Under the conditions of our assays, mast cells derived from a single lineage-committed progenitor did not produce heparin in response to continuous stimulation with SCF. When mast cells from various methylcellulose cultures were cocultured with a fibroblast cell line derived from normal mice, significant numbers of safranin-positive mast cells were observed. The same result was obtained when mast cells were cocultured with a fibroblast cell line derived from Sl/Sld mice, provided that cytokines were added to support cell viability. Because Sl/Sld mice are known to be defective in their production of membrane-bound SCF,3 our data provide further evidence that neither soluble nor membranebound SCF is sufficient to stimulate the phenotypic changes associated with the emergence of heparin-positive CTMCs. Given that SCF is critical for the in situ development of both mucosal mast cells and CTMCS,".~~.~' it appears that other factors, unique to specific anatomical locations, control the final stages of mast cell differentiation.
